Abstract
Background: Donor bone marrow transplantation (BMT) may promote chimerism in solid organ and composite tissue allografts. This study was designed to evaluate the rationale of immunotherapy with adoptive transfer of donor-specific cells originated from two different MHC mismatched donors and transplanted to the same recipients. Methods: Seven primary trimera were created across the MHC barrier from LBN (RT1n) (n = 7) and ACI (RT1a) (n = 7) donors to LEW (RT1l) recipients (n = 7), under a 7-day protocol of αβ-TCRmAb/CsA therapy.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
